Apixaban Modified-Release Tablets(Taizhou Overseas Pharma)

阿哌沙班多释片(泰州越洋医药)

Report date: 2025/08/20 15:22:30

Base Information

Drug NameApixaban Modified-Release Tablets(Taizhou Overseas Pharma)
Drug Alias NameApixabanum阿匹沙班艾吡沙班阿派沙班
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous Thromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVenous Thromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A